Search

everythinglearnresearchcommunity

for

Search:↓

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

Immunosuppression therapy with methylprednisolone effectively treats childhood alopecia areata.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Fibroblasts from healthy donors can prevent changes seen in recessive epidermolysis bullosa simplex.

Moderate immune responses help hair growth, while excessive responses slow it down.

Adding collagenase to trypsin improves cell yield and repigmentation in vitiligo treatment.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.

Gentamicin-loaded exosomes improve healing of infected diabetic wounds in mice.

Genetically modified cells can regenerate skin and hair in rats.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Transplanting melanocyte stem cells from hair follicles can effectively treat vitiligo.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Correct diagnosis and treatment are crucial for effective management of lipid storage myopathies.

Fibroblasts can be turned into melanocytes for potential skin treatments.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Old treatments for other skin conditions showed promise for hair regrowth in mice with a hair loss condition.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

MicroRNAs can reprogram cells into stem cells faster and more efficiently than traditional methods.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

IL-27 may help prevent hair loss by creating immune-suppressing cells.